Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2008
10/23/2008WO2008127718A2 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
10/23/2008WO2008127700A1 Methods for inhibiting hepatitis virus type c
10/23/2008WO2008127680A2 Diagnosis and treatment of diseases caused by misfolded proteins
10/23/2008WO2008127629A1 Consortial growth of microorganisms for fuel feedstocks
10/23/2008WO2008127603A2 Transient receptor potential vanilloid 1 and uses thereof
10/23/2008WO2008127526A2 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
10/23/2008WO2008127524A2 Biomarkers of very rapid antidepressant response and of mechanism of very rapid antidepressant response
10/23/2008WO2008127496A2 Heavy metal biosensor
10/23/2008WO2008127414A2 Colorimetric detection of metallic ions in aqueous media using functionlized nanoparticles
10/23/2008WO2008127363A2 Devices for generating detectable polymers
10/23/2008WO2008127356A2 Methods and kits for isolating cells
10/23/2008WO2008127317A2 Alternatively spliced pre-mrna transcripts as biomarkers in idiopathic neurodegenerative diseases
10/23/2008WO2008127248A1 Gene defects and mutant alk kinase in human solid tumors
10/23/2008WO2008127213A2 Methods, systems, and software for regulated oligonucleotide-mediated recombination
10/23/2008WO2008127101A1 Involvement of lipid kinase, and signal transduction pathway comprising said lipid kinase, in resistance to her2-targeting therapy
10/23/2008WO2008126940A1 Novel t cell
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126837A1 Labelable nucleic acid, labeled nucleic acid and use thereof
10/23/2008WO2008126827A1 Temperature control device, and temperature control method
10/23/2008WO2008126430A1 Method for evaluation of tissue preservation solution
10/23/2008WO2008126111A1 A chemosusceptibility rapid test for helicobacter pylori
10/23/2008WO2008126107A2 Genetic variants associated with periodic limb movements and restless legs syndrome
10/23/2008WO2008126081A1 A method and test kit for the rapid identification and characterization of cells
10/23/2008WO2008125883A1 Cancer markers for prognosis and screening of anti-cancer agents
10/23/2008WO2008125836A2 Methods and uses related to rhbdl4
10/23/2008WO2008125791A1 Cancer markers
10/23/2008WO2008125770A1 Method for detecting fungal contamination
10/23/2008WO2008125738A2 A method for selecting responders to blockade of integrin receptors
10/23/2008WO2008125725A1 Modified routes of lipid metabolism, measuring oxidized ldl after fat loading.
10/23/2008WO2008125724A1 Estimation and biological consequences of oxidative metabolism
10/23/2008WO2008125612A1 Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on egfr/csf-1/ca ix expression
10/23/2008WO2008125513A1 Biosensor and the production thereof
10/23/2008WO2008125365A1 Microbial population analysis
10/23/2008WO2008125247A2 Novel medical diagnostic method and therapy in the context of interferon-stimulated genes that induce depression
10/23/2008WO2008124937A1 Alleles and polymorphisms predictive of responsiveness to biologic therapy in psoriasis
10/23/2008WO2008124933A1 Carbon and nitrogen-regulating gene and protein and modulation thereof
10/23/2008WO2008104679A3 Medium for the detection and/or identification of bacteria
10/23/2008WO2008104002A8 Methods for rapid forensic dna analysis
10/23/2008WO2008103692A3 Methods of identifying activators of lyn kinase
10/23/2008WO2008097887A3 Methods of direct genomic selection using high density oligonucleotide microarrays
10/23/2008WO2008097353A3 Reduced activity of ubica in e. coli
10/23/2008WO2008091913A3 Method for accurate assessment of dna quality after bisulfite treatment
10/23/2008WO2008086002A3 Slco1b3 genotype
10/23/2008WO2008083251A3 Dna methylation markers based on epigenetic stem cell signatures in cancer
10/23/2008WO2008081094A3 Method for the functional measurement of plasmatic thromboduline activity
10/23/2008WO2008076784A3 Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies
10/23/2008WO2008075790A8 Method for detecting cancer with nucleic acids in blood
10/23/2008WO2008073915A3 Micrornas differentially expressed in leukemia and uses thereof
10/23/2008WO2008073635A9 Automatable artificial immune system (ais)
10/23/2008WO2008073316A3 Identification and isolation of acute myeloid leukemia stem cells
10/23/2008WO2008072192A3 Biological assay substrate and method and device for producing such substrate
10/23/2008WO2008067180A3 Centrosomal proteins and secretion
10/23/2008WO2008061196A3 Methods and kits for detecting jak2 nucleic acid
10/23/2008WO2008054947A8 Structure of acid beta-glucosidase and methods for identifying therapeutic agents
10/23/2008WO2008054534A9 Screening systems utilizing rtp801
10/23/2008WO2008047128A3 Materials and methods for determining susceptibility to cancer
10/23/2008WO2008032210A3 Methods of using sip-10 to assess hcv clearance and/or response to interferon therapy
10/23/2008WO2008024493A3 A method of detecting one or more limited copy targets
10/23/2008WO2008021010A3 Methods for real-time quantitative pcr
10/23/2008WO2008014373A3 Hspa1a as a marker for sensitivity to ksp inhibitors
10/23/2008WO2008005418A3 Assays for tak1 activity
10/23/2008WO2008005375A3 Kidney toxicity biomarkers
10/23/2008WO2007124440A3 Novel polymorphism in bovine prion protein gene sequence
10/23/2008WO2007124309A3 Methods for detecting mutations in jak2 nucleic acid
10/23/2008WO2007117700A3 In situ cloning from pathological tissue specimens
10/23/2008WO2007112418A3 Screening for down syndrome
10/23/2008WO2007100793A3 Microarray having a base cleavable sulfonyl linker
10/23/2008WO2007100762A3 Use of phenanthridium derivatives for distinguishing between intact and membrane-compromised cells using molecular nucleic acid-based techniques
10/23/2008WO2007087646A3 Methods of diagnosing, predicting therapeutic efficacy and screening for new therapeutic agents for leukemia
10/23/2008WO2007075935A3 A method of forming a multilayer test sensor
10/23/2008WO2007075929A3 Methods and applications of molecular beacon imaging for identifying and validating genomic targets, and for drug screening
10/23/2008WO2006099207A3 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/23/2008WO2005113798A3 Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
10/23/2008US20080263726 Short vegetative phase (SVP) gene protein for enhancing flowering time in crop plants
10/23/2008US20080263690 Neuregulin-1 transgenic mouse and methods of use
10/23/2008US20080263689 Screening/monitoring rate of internalization of insulin receptors in insulin-stimulated hepatocytes; identifying modulators of insulin clearance and secretion; treating insulin resistance
10/23/2008US20080263685 Transgenic non-human animal expressing metabotropic glutamate receptor 1 in a melanocyte-specific manner for identifying modulators for prevention and treatment of cell proliferative disorders
10/23/2008US20080263684 Pik4ca As Modifier of the Rac Pathway and Methods of Use
10/23/2008US20080262384 determining the presence or absence of pre-cancerous or cancerous cells in a urogenital sample and for diagnosis of dysplasia or neoplasia; using fluorescently labeled probing agents that specifically recognizes biomarkers
10/23/2008US20080262321 Early Detection of Harmful Agents: Method, System and Kit
10/23/2008US20080262213 Bioreactor comprising solid support containing immobilized polylysine for use in propagation of polynucleotide sequences
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262093 Contacting a cell expressing PGC-1 with various amount of respiration uncoupling agent to determing the resulting maximum PGC-1 level and therefore the upper limit of the safe dosage for the agent; decreasing fat mass/adipocity or increasing weight loss; antidiabetic agents; eating/metabolic disorders
10/23/2008US20080262087 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners
10/23/2008US20080262062 disease treatable with PARP modulators by identifying a level of PARP in a plurality of samples from a population, making a decision regarding identifying the disease treatable by the PARP modulators wherein the decision is made based on the level of PARP
10/23/2008US20080261910 Diagnostic Methods Based on Polymorphisms of Glucosyltransferase-Like Protein
10/23/2008US20080261908 Adverse prognostic markers estrogen receptor, progesterone receptor expression, positive lymph node metastasis, high proliferative index, detectable p53 expression; identify breast cancer-specific signature of miRNAs differentially-expressed in breast cancer cells relative to normal control cells
10/23/2008US20080261906 Screen for agents that modulate replication of hepatitis C virus; detect binding modulators of TBC and NS5A, inhibition of TBC activity, inhibition of Rab1 activity, expression of the TBC protein and/or Rab1 protein
10/23/2008US20080261904 Synthesized oligomers complementary to and capable of hybridizing to a selected target nucleic acid; internucleoside linking; three regions differentiated by differentially modified ribofuranosyl sugar moieties; antisense and sense oligomeric compound; inhibiting gene expression
10/23/2008US20080261903 Isolated polynucleotide encoding a Regulated in chronic obstructive pulmonary disease Kinase polypeptide; host cell; hybridization; screening; prediction, diagnosis; prognosis; chronic obstructive pulmonary disease, asthma, cancer, diseases of defective cell signaling
10/23/2008US20080261889 Using variation in mannan-binding lectin (MBL) gene as diagnostic/prognostic indicator; Alzheimer's disease
10/23/2008US20080261883 Runx3 gene showing anti-tumor activity and use thereof
10/23/2008US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors
10/23/2008US20080261870 Use of the Pro-Peptide Domain of Lysyl Oxidase as a Therapeutic Agent
10/23/2008US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents
10/23/2008US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/23/2008US20080261826 Manufacture And Use Of Non-Standard Size Microarray Slides
10/23/2008US20080261824 Identifies novel set of genes specifically expressed in chemosensory or more specifically taste cells, e.g., mouse circumvallate taste cells, and likely taste cells derived from other mammals such as humans and non-human primates; "taste-specific" genes; identifying compounds useful as therapeutics
10/23/2008US20080261822 Non-invasive prenatal genetic diagnosis using transcervical cells
1 ... 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 ... 3003